1. Home
  2. NRXP vs MAGH Comparison

NRXP vs MAGH Comparison

Compare NRXP & MAGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NRXP
  • MAGH
  • Stock Information
  • Founded
  • NRXP 2015
  • MAGH 2012
  • Country
  • NRXP United States
  • MAGH Singapore
  • Employees
  • NRXP N/A
  • MAGH N/A
  • Industry
  • NRXP Biotechnology: Pharmaceutical Preparations
  • MAGH Engineering & Construction
  • Sector
  • NRXP Health Care
  • MAGH Industrials
  • Exchange
  • NRXP Nasdaq
  • MAGH Nasdaq
  • Market Cap
  • NRXP 58.5M
  • MAGH 51.8M
  • IPO Year
  • NRXP N/A
  • MAGH 2025
  • Fundamental
  • Price
  • NRXP $2.92
  • MAGH $1.67
  • Analyst Decision
  • NRXP Strong Buy
  • MAGH
  • Analyst Count
  • NRXP 5
  • MAGH 0
  • Target Price
  • NRXP $31.40
  • MAGH N/A
  • AVG Volume (30 Days)
  • NRXP 435.6K
  • MAGH 210.5K
  • Earning Date
  • NRXP 11-13-2025
  • MAGH 11-08-2025
  • Dividend Yield
  • NRXP N/A
  • MAGH N/A
  • EPS Growth
  • NRXP N/A
  • MAGH N/A
  • EPS
  • NRXP N/A
  • MAGH 0.00
  • Revenue
  • NRXP N/A
  • MAGH $11,752,129.00
  • Revenue This Year
  • NRXP N/A
  • MAGH N/A
  • Revenue Next Year
  • NRXP $395.09
  • MAGH N/A
  • P/E Ratio
  • NRXP N/A
  • MAGH $1,777.24
  • Revenue Growth
  • NRXP N/A
  • MAGH N/A
  • 52 Week Low
  • NRXP $1.12
  • MAGH $0.99
  • 52 Week High
  • NRXP $6.01
  • MAGH $5.15
  • Technical
  • Relative Strength Index (RSI)
  • NRXP 41.65
  • MAGH N/A
  • Support Level
  • NRXP $3.05
  • MAGH N/A
  • Resistance Level
  • NRXP $3.32
  • MAGH N/A
  • Average True Range (ATR)
  • NRXP 0.22
  • MAGH 0.00
  • MACD
  • NRXP -0.05
  • MAGH 0.00
  • Stochastic Oscillator
  • NRXP 0.74
  • MAGH 0.00

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

About MAGH Magnitude International Ltd Ordinary Shares

Magnitude International Ltd is providing electrical installation services to customers in both the private and public sectors in Singapore. It includes the planning, design, material selection, installation, testing, commissioning and certification of the electrical equipment/systems to be installed. The Group's revenue is derived from Singapore.

Share on Social Networks: